Every year on 28 July, WHO and partners mark World Hepatitis Day to increase awareness and understanding of viral hepatitis and the diseases that it causes. World Hepatitis Day provides an opportunity to step up national and international efforts on hepatitis, to encourage actions and engagement by individuals, partners, and the public, and to highlight the need for a greater global response.
Drug discovery has played a crucial role in developing antiviral drugs to cure hepatitis C, one of the leading causes of liver cancer and cirrhosis. These drugs have transformed the treatment landscape, and many people living with hepatitis C can now be cured with just a few weeks of medication. However, more research is needed to develop effective treatments for hepatitis B, which still affects over 250 million people globally.
To support anti-hepatitis drug discovery worldwide, Life Chemicals is offering its Anti-hepatitis Screening Libraries, as well as a collection of related screening libraries for hepatitis-related targets:
- Antiviral Libraries
- Helicase Focused Library
- Serine Protease Focused Library
- Protein-Protein Interactions (PPI) Screening Libraries: Ligand-Based Approach
Please, contact us at marketing@lifechemicals.com for any additional information and price quotations.
Visit our Website for a detailed product description, or place an order online on our E-commerce website.
Download SD files with compound structures directly from our Downloads section
Custom compound selection based on specific parameters can be performed on request, with competitive pricing and the most convenient terms provided.